Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Octapharma receives approval to distribute drug in the USA
Lachen/Paramus - Octapharma USA has received approval in the USA for its drug Balfaxar, which is marketed as Octaplex in Europe and Canada. Before surgery, the drug helps to rapidly restore blood clotting after this may have been suppressed following a heart attack.
CARIFY collaborating with LeaseTeq
Härkingen/Pfäffikon - CARIFY has entered into a partnership with the leasing financer LeaseTeq. Together, the two companies plan to offer refinancing to Swiss car dealers.
Artificial intelligence designs fashion for FTC
Horgen - The cashmere specialist Art of Cashmere World is receiving inspiration from generative artificial intelligence (AI) in the creative process for the designs of its FTC brand. The Midjourney platform creates suggestions that are then revised. AI has also been integrated into product management.
ANYbotics concludes partnership in Japan
Zurich/Tokyo - Tokyo-based company Nihon Binary is the new sales partner of ANYbotics’ ANYmal autonomous inspection robot. It is to be implemented in Japan’s oil and gas industries above all as well as in the chemical, energy, metal, and transport sectors.
vrbn studios offers 3D content in new online shop
Uster - vrbn studios, a business unit of vrbn, has set up an online shop offering high-quality architectural 3D environments and 3D buildings. These tools are used in gaming, advertising, film and TV, and simulations – for example, for autonomous driving.
InSphero announces an award for 3D in vitro models
Schlieren/Washington - InSphero, based in the canton of Zurich, and the Physicians Committee for Responsible Medicine have launched a joint award program. Five academic teams will be provided with InSphero 3D microtissues aimed at furthering the development or validation of 3D in vitro models.
ETH BiodivX makes the final of biodiversity competition
Zurich/Birmensdorf - The ETH BiodivX team under the leadership of the Swiss Federal Institute of Technology in Zurich (ETH) and the Swiss Federal Institute for Forest, Snow and Landscape Research (WSL) is one of the finalists in the XPRIZE Rainforest Competition being held over a period of five years. The ream is researching biodiversity with the help of drones and rovers. The competition comes with prize money of 10 million US dollars.
LimmaTech Bio cooperating with GSK on vaccine development
Schlieren/London - The biotechnology firm LimmaTech Biologics has concluded a license agreement with GlaxoSmithKline Biologicals (GSK). In this way, LimmaTech is seeking to drive the development of a multivalent vaccine. At the same time, the company has announced the appointment of Franz-Werner Haas as its new CEO.
Rapid test from ETH Zurich to facilitate more targeted treatment for bladder infections
Zurich - Researchers from the Swiss Federal Institute of Technology in Zurich (ETH) have developed a new test for bacterial bladder infections. The research approach is based on the use of bacteriophages. The aim is help counteract rising antibiotic resistance.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space